Mechanisms underlying the inhibitory effects of tachykinin receptor antagonists on eosinophil recruitment in an allergic pleurisy model in mice

British Journal of Pharmacology

Volumn 140, Issue 5, 2003, Pages 847-854

  Alessandri, Ana Letícia ^a   Pinho, Vanessa ^a   Souza, Danielle G ^a   Castro, Maria Salete De A ^a   Klein, André ^a,b   Teixeira, Mauro M ^a,c  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Bone marrow; Eosinophil recruitment; Eotaxin; IL 5; LTB 4

Indexed keywords

CAPSAICIN; EOTAXIN; INTERLEUKIN 5; LEUKOTRIENE B4; NOLPITANTIUM; OSANETANT; SAREDUTANT; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR ANTAGONIST;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; EOSINOPHIL; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PLEURA CAVITY; PLEURISY; PRIORITY JOURNAL; SENSORY NERVE;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; FEMALE; MICE; MICE, INBRED BALB C; PIPERIDINES; PLEURISY; QUINUCLIDINES; RECEPTORS, TACHYKININ;

EID: 0344873165     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705515     Document Type: Article

References (57)

1. 1 receptors mediate leukocyte adhesion in neurogenic inflammation in rat trachea. Am. J. Physiol., 268, L263-L269.
2. CARA, D.C., NEGRAO-CORREA, D. & TEIXEIRA, M.M. (2000). Mechanisms underlying eosinophil trafficking and their relevance in vivo. Histol. Histopathol., 15, 899-920.
3. CONROY, D.M. & WILLIAMS, T.J. (2001). Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir. Res., 2, 150-156.
4. 1 receptor antagonists on vagal hyperreactivity and neuronal M2 muscarinic receptor function in antigen challenged guinea-pigs. Br. J. Pharmacol., 124, 267-276.
5. D'AGOSTINO, B., ADVENIER, C., DE PALMA, R., GALLELLI, L., MARROCCO, G., ABBATE, G.F. & ROSSI, F. (2002). The involvement of sensory neuropeptides in airway hyper-responsiveness in rabbits sensitized and challenged to Parictaria judaica. Clin. Exp. Allergy, 32, 472-479.
6. DAOUI, S., AHNAOU, A., NALINE, E., EMONDS-ALT, X., LAGENTE, V. & ADVENIER, C. (2001). Tachykinin NK(3) receptor agonists induced microvascular leakage hypersensitivity in the guinea-pig airways. Eur. J. Pharmacol., 433, 199-207.
7. DAS, A.M., FLOWER, R.J., HELLEWELL, P.G., TEIXEIRA, M.M. & PERRETTI, M. (1997). A novel murine model of allergic inflammation to study effect of dexamethasone on eosinophil recruitment. Br. J. Pharmacol., 121, 97-104.
8. DICKERSON, C., UNDEM, B., BULLOCK, B. & WINCHURCH, R. (1998). Neuropeptides regulation of proinflammatory cytokine responses. J. Leukocyte Biol., 63, 602-605.
9. DUNZENDORFER, S., MEIERHOFER, C. & WIEDERMANN, C.J. (1998). Signaling in neuropeptide-induced migration of human cosinophils. J. Leukocyte Biol., 64, 828-834.
10. EL-SHAZLY, A. & ISHIKAWA, S.P. (1999). Novel co-operation between eotaxin and subtance-P in inducing eosinophil-derived neurotoxin release. Mediators Inflamm., 8, 177-179.
11. FOSTER, P.S., HOGAN, S.P., RAMSAY, A.J., MATTHAEI, K.I. & YOUNG, I.G. (1996). Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med., 183, 195-201.
12. FRODE-SALEH, T.S., CALIXTO, J.B. & MEDEIROS, Y.S. (1999). Analysis of the inflammatory response induced by substance P in the mouse pleural cavity. Peptides, 20, 259-265.
13. GEPPETTI, P. (1993). Sensory neuropeptide release by bradykinin: mechanisms and pathophysiological implications. Regul. Peptides, 47, 1-23.
14. GEPPETTI, P., DEL BIANCO, E., PATACCHINI, R., SANTICIOLI, P., MAGGI, C.A. & TRAMONTANA, M. (1991). Low pH-induced release of calcitonin gene-related peptide from capsaicin-sensitive sensory nerves: mechanism of action and biological response. Neuroscience, 41, 295-301.
15. GIEMBYCZ, M.A. & LINDSAY, M.A. (1999). Pharmacology of the eosinophil. Pharmacol. Rev., 51, 213-340.
16. GONZALO, J.A., JIA, G.Q., AGUIRRE, V., FRIEND, D., COYLE, A.J., JENKINS, N.A., LIN, G.S., KATZ, H., LICHTMAN, A., COPELAND, N., KOPF, M. & GUTIERREZ-RAMOS, J.C. (1996). Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity, 4, 1-14.
17. HARRISON, S. & GEPPETTI, P. (2001). Substance P. Int. J. Biochem. Cell Biol., 33, 555-576.
18. HOLZER, P. (1991). Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev., 43, 143-201.
19. HOLZER, P. (1998). Neurogenic vasodilatation and plasma leakage in the skin. Gen. Pharmac., 30, 5-11.
20. HUA, X.Y., BACK, S.M. & TAM, E.K. (1996). Substance P enhances electrical field stimulation-induced mast cell degranulation in rat trachea. Am. J. Physiol., 270, L985-L991.
21. HUMBLES, A.A., CONROY, D.M., MARLEAU, S., RANKIN, S.M., PALFRAMAN, R.T., PROUDFOOT, A.E., WELLS, T.N., LI, D., JEFFERY, P.K., GRIFFITHS-JOHNSON, D.A., WILLIAMS, T.J. & JOSE, P.J. (1997). Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J. Exp. Med., 186, 601-612.
22. INOUE, H., NAGATA, N. & KOSHIHARA, Y. (1996). Involvement of tachykinin receptors in oedema formation and plasma extravasation induced by substance P, neurokinin A, and neurokinin B in mouse ear. Inflamm. Res., 45, 316-323.
23. 4 mediates substance P-induced granulocyte infiltrating into mouse skin. J. Immunol., 151, 2116-2123.
24. JANCSO, G., KIRALY, E. & JANCSO-GABOR, A. (1977). Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature, 270, 741-743.
25. KARIMI, K., REDEGELD, F.A., BLOM, R. & NIJKAMP, P.P. (2000). Stem cell factor and interleukin-4 increase responsiveness of mast cells to substance P. Exp. Hematol., 28, 626-634.
26. KLEIN, A., PINHO, V., ALESSANDRI, A.L., SHIMIZU, T., ISHII, S. & TEIXEIRA, M.M. (2002). Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice. Br. J. Pharmacol., 135, 1213-1218.
27. 4. J. Immunol., 164, 4271-4276.
28. KLEIN, A., TALVANI, A., SILVA, P.M., MARTINS, M.A., WELLS, T.N., PROUDFOOT, A., LUCKACS, N.W. & TEIXEIRA, M.M. (2001). Stem cell factor-induced leukotriene B4 production cooperates with cotaxin to mediate the recruitment of eosinophils during allergic pleurisy in mice. J. Immunol., 167, 524-531.
29. KOPF, M., BROMBACHER, F., HODGKIN, P.O., RAMSAY, A.J., MILBOURNE, E.A., DAI, W.J., OVINGTON, K.S., BEHM, C.A., KOHLER, G., YOUNG, I.G. & MATTHAEI, K.I. (1996). IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity, 4, 15-24.
30. KRANEVELD, A.D., NIJKAMP, P.P. & VAN OOSTERHOUT, A.J. (1997). Role for neurokinin-2 receptor in interleukin-5-induced airway hyperresponsiveness but not eosinophilia in guinea pigs. Am. J. Respir. Crit. Care Med., 156, 367-374.
31. 2 tachykinin receptors and their involvement in histamine release in a murine mast cell line. Neuropeptides. 21, 65-72.
32. KRUMINS, S.A. & BROOMFIELD, C.A. (1993). C-terminal substance P fragments elicit histamine release from a murine mast cell line. Neuropeptides. 24, 5-10.
33. KUDLACZ, E.M., KNIPPENBERG, R.W., LOGAN, D.E. & BURKHOLDER, T.P. (1996). Effect of MDL 105,212, a nonpeptide NK-1/NK-2 receptor antagonist in an allergic guinea pig model. J. Pharmacol. Exp. Ther., 279, 732-739.
34. LAU, A.H.Y., CHOW, S.S.M. & NG, Y.S. (2001). Immunologically induced histamine release from rat peritoneal mast cells is enhanced by low levels of substance P. Eur. J. Pharmacol., 414, 295-303.
35. LILLY, C.M., HALL, A.E., RODGER, I.W., KOBZIK, L., HALEY, K.J. & DRAZEN, J.M. (1995). Substance P-induced histamine release in tracheally perfused guinea pig lungs. J. Appl. Physiol., 78, 1234-1241.
36. MAGGI, C.A. (1997). The effects of tachykinin on inflammatory and immune cells. Regul. Peptides, 70, 75-90.
37. MATSUDA, H., KAWAKITA, K., KISO, Y., NAKANO, T. & KITAMURA, Y. (1989). Substance P induces granulocyte infiltrating through degranulation of mast cells. J. Immunol., 142, 927-931.
38. MOULD, A.W., MATTHAEI, K.I., YOUNG, I.G. & FOSTER, P.S. (1997). Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Cin. Invest., 99, 1064-1071.
39. 1 receptor antagonist, FK888, on constriction and plasma extravasation induced in guinea pig airway by neurokinins and capsaicin. Eur. J. Pharmacol., 236, 7-13.
40. NÇNAN, S., GERMAIN, N., LAGENTE, V., EMONDS-ALT, X., ADVENIER, C. & BOICHOT, E. (2001). Inhibition of inflammatory cell recruitment by the tachykinin NK(3)-receptor antagonist, SR 142801, in a murine model of asthma. Eur. J. Pharmacol., 421, 201-205.
41. NUMAO, T. & AGRAWAL, D.K. (1992). Neuropeptides modulate human eosinophil chemotaxis. J. Immunol., 149, 3309-3315.
42. OKABE, T., HIDE, M., KORO, O., NIMI, N. & YAMAMOTO, S. (2001). The release of leukotriene B4 from human skin in response to substance P: evidence for the functional heterogeneity of human skin mast cells among individuals. Clin. Exp. Immunol., 124, 150-156.
43. PHILLIPS, J.E., HEY, J.A. & CORBOZ, M.R. (2003). Tachykinin NK(3) and NK(I) receptor activation elicits secretion from porcine airway submucosal glands. Br. J. Pharmacol., 138, 254-260.
44. QUARTARA, L. & MAGGI, C.A. (1998). The tachykinin NK, receptor Part II: distribution and pathophysiological roles. Neuropeptides, 32, 1-49.
45. ROTHENBERG, M.E. (1999). Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues. Am. J. Respir. Cell Mol. Biol., 21, 291-295.
46. SABAN, M.R., SABAN, R., BJORLING, D. & HAAK-FRENDSCHO, M. (1997). Involvement of leukotrienes, TNF-α, and LFA-1/CAM-1 interaction in substance P-induced granulocyte infiltration. J. Leukocyte Biol., 61, 445-451.
47. SANDERSON, C.J. (1992). Interleukin-5, eosinophils, and disease. Blood, 97, 3101-3109.
48. SCHRODER, J.M., NOSO, N., STICHERLING, M. & CHRISTOPHERS, E. (1996). Role of eosinophil-chemotactic C-C chemokines in cutaneous inflammation. J. Leukocyte Biol., 59, 1-5.
49. 1 receptor in the development of allergen-induced airway hyperreactivity and airway inflammatory in conscious, unrestrained guinea-pig. Am. J. Respir. Crit. Care Med., 159, 423-430.
50. 2 receptors in allergen-induced early and late asthmatic reactions, airway hyperresponsiveness, and airway inflammation in conscious, unrestrained guinea pigs. Clin. Exp. Allergy, 29, 48-52.
51. SEVERINI, C., IMPROTA, G., FALCONIERI-ERSPAMER, G., SALVADORI, S. & ERSPAMER, V. (2002). The tachykinin peptide family. Phannacol. Rev., 54, 285-322.
52. SMITH, C.H., BARKER, J.N., MORRIS, R.W., MACDONALD, D.M. & LEE, T.H. (1993). Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J. Immunol., 151, 3274-3282.
53. TEIXEIRA, M.M. & HELLEWELL, P.G. (1994). Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig. Br. J. Pharmacol., 1111, 1205-1211.
54. TEIXEIRA, M.M., WELLS, T.N., LUKACS, N.W., PROUDFOOT, A.E., KUNKEL, S.L., WILLIAMS, T.J. & HELLEWELL, P.G. (1997). Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J. Clin. Invest., 100, 1657-1666.
55. TRAMONTANA, M., SANTICIOLI, P., GIULIANI, S., CATALIOTO, R.M., LECCI, A., CARINI, F. & MAGGI, C.A. (2002). Role of tachykinins in scphadex-induced airway hyperreactivity and inflammation in guinea pigs. Eur. J. Pharmacol., 439, 149-158.
56. 4 antagonism in a primate model of asthma. J. Clin. Invest., 97, 381-387.
57. 1 receptor antagonists and the role of endogenous mediators. Br. J. Pharmacol., 114, 1343-1350.